

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | muscle filament sliding (GO:0030049) | 9.07685221 |
| 2 | actin-myosin filament sliding (GO:0033275) | 9.07685221 |
| 3 | sarcomere organization (GO:0045214) | 8.83337294 |
| 4 | regulation of skeletal muscle contraction (GO:0014819) | 8.44079609 |
| 5 | myofibril assembly (GO:0030239) | 7.54247197 |
| 6 | actin-mediated cell contraction (GO:0070252) | 7.46150237 |
| 7 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.44907402 |
| 8 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.39618218 |
| 9 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 7.27327350 |
| 10 | cardiac myofibril assembly (GO:0055003) | 7.24938428 |
| 11 | plasma membrane repair (GO:0001778) | 6.69963267 |
| 12 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.53414699 |
| 13 | skeletal muscle contraction (GO:0003009) | 6.30973972 |
| 14 | cardiac muscle contraction (GO:0060048) | 6.17841849 |
| 15 | * regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.16955256 |
| 16 | tricarboxylic acid cycle (GO:0006099) | 6.16481522 |
| 17 | skeletal muscle fiber development (GO:0048741) | 6.14548739 |
| 18 | striated muscle contraction (GO:0006941) | 6.02935024 |
| 19 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.84807063 |
| 20 | regulation of relaxation of muscle (GO:1901077) | 5.84484017 |
| 21 | carnitine shuttle (GO:0006853) | 5.83732504 |
| 22 | regulation of cell communication by electrical coupling (GO:0010649) | 5.76426532 |
| 23 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.69384016 |
| 24 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.69176006 |
| 25 | actomyosin structure organization (GO:0031032) | 5.65747657 |
| 26 | regulation of actin filament-based movement (GO:1903115) | 5.61260816 |
| 27 | actin filament-based movement (GO:0030048) | 5.57693372 |
| 28 | cardiac muscle cell development (GO:0055013) | 5.56732126 |
| 29 | myotube cell development (GO:0014904) | 5.54996238 |
| 30 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.40528598 |
| 31 | skeletal muscle adaptation (GO:0043501) | 5.29568788 |
| 32 | cardiac cell development (GO:0055006) | 5.21455917 |
| 33 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.18797965 |
| 34 | creatine metabolic process (GO:0006600) | 5.15508013 |
| 35 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.14278910 |
| 36 | fatty acid transmembrane transport (GO:1902001) | 5.03071333 |
| 37 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.01408253 |
| 38 | regulation of sarcomere organization (GO:0060297) | 4.87242291 |
| 39 | regulation of striated muscle contraction (GO:0006942) | 4.77609069 |
| 40 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.75889208 |
| 41 | regulation of cofactor metabolic process (GO:0051193) | 4.70599748 |
| 42 | regulation of coenzyme metabolic process (GO:0051196) | 4.70599748 |
| 43 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.68811452 |
| 44 | cardiac muscle hypertrophy (GO:0003300) | 4.67649876 |
| 45 | heart process (GO:0003015) | 4.65857258 |
| 46 | heart contraction (GO:0060047) | 4.65857258 |
| 47 | adult heart development (GO:0007512) | 4.61102713 |
| 48 | skeletal muscle tissue development (GO:0007519) | 4.58309522 |
| 49 | striated muscle hypertrophy (GO:0014897) | 4.57374132 |
| 50 | skeletal muscle tissue regeneration (GO:0043403) | 4.47804518 |
| 51 | regulation of membrane repolarization (GO:0060306) | 4.43201198 |
| 52 | heart trabecula formation (GO:0060347) | 4.36946651 |
| 53 | muscle contraction (GO:0006936) | 4.35767728 |
| 54 | glycogen catabolic process (GO:0005980) | 4.34080207 |
| 55 | muscle tissue morphogenesis (GO:0060415) | 4.33125568 |
| 56 | carnitine transmembrane transport (GO:1902603) | 4.32658057 |
| 57 | response to inactivity (GO:0014854) | 4.24271249 |
| 58 | striated muscle adaptation (GO:0014888) | 4.16314931 |
| 59 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.10057015 |
| 60 | muscle atrophy (GO:0014889) | 4.08449191 |
| 61 | response to muscle activity (GO:0014850) | 4.08060526 |
| 62 | muscle cell cellular homeostasis (GO:0046716) | 4.06875479 |
| 63 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.05587536 |
| 64 | glucan catabolic process (GO:0009251) | 4.05274354 |
| 65 | muscle hypertrophy (GO:0014896) | 4.03812257 |
| 66 | muscle system process (GO:0003012) | 4.02064883 |
| 67 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.01667033 |
| 68 | carnitine transport (GO:0015879) | 3.94261589 |
| 69 | amino-acid betaine transport (GO:0015838) | 3.94261589 |
| 70 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.93100522 |
| 71 | fructose metabolic process (GO:0006000) | 3.91577987 |
| 72 | NADH metabolic process (GO:0006734) | 3.90074002 |
| 73 | 2-oxoglutarate metabolic process (GO:0006103) | 3.89692498 |
| 74 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.88163670 |
| 75 | muscle adaptation (GO:0043500) | 3.87807826 |
| 76 | glycogen metabolic process (GO:0005977) | 3.86056377 |
| 77 | striated muscle atrophy (GO:0014891) | 3.86050629 |
| 78 | positive regulation of myotube differentiation (GO:0010831) | 3.85384741 |
| 79 | striated muscle cell development (GO:0055002) | 3.85126055 |
| 80 | response to activity (GO:0014823) | 3.85029125 |
| 81 | regulation of sulfur metabolic process (GO:0042762) | 3.84175211 |
| 82 | gluconeogenesis (GO:0006094) | 3.82680316 |
| 83 | cellular glucan metabolic process (GO:0006073) | 3.78483096 |
| 84 | glucan metabolic process (GO:0044042) | 3.78483096 |
| 85 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.78130205 |
| 86 | cellular polysaccharide catabolic process (GO:0044247) | 3.77651837 |
| 87 | muscle organ development (GO:0007517) | 3.75855902 |
| 88 | muscle structure development (GO:0061061) | 3.75659357 |
| 89 | muscle cell fate commitment (GO:0042693) | 3.74385843 |
| 90 | respiratory electron transport chain (GO:0022904) | 3.73213250 |
| 91 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.72490187 |
| 92 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.72490187 |
| 93 | regulation of sequestering of triglyceride (GO:0010889) | 3.69947794 |
| 94 | oxidative phosphorylation (GO:0006119) | 3.65402684 |
| 95 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.64735825 |
| 96 | muscle hypertrophy in response to stress (GO:0003299) | 3.64735825 |
| 97 | cardiac muscle adaptation (GO:0014887) | 3.64735825 |
| 98 | electron transport chain (GO:0022900) | 3.61360806 |
| 99 | muscle fiber development (GO:0048747) | 3.61088303 |
| 100 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.60938326 |
| 101 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.60938326 |
| 102 | regulation of the force of heart contraction (GO:0002026) | 3.60828427 |
| 103 | muscle organ morphogenesis (GO:0048644) | 3.60035677 |
| 104 | negative regulation of potassium ion transport (GO:0043267) | 3.58766167 |
| 105 | cell communication involved in cardiac conduction (GO:0086065) | 3.57975165 |
| 106 | ATP synthesis coupled proton transport (GO:0015986) | 3.57159880 |
| 107 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.57159880 |
| 108 | polysaccharide catabolic process (GO:0000272) | 3.56439271 |
| 109 | cytidine deamination (GO:0009972) | 3.54739731 |
| 110 | cytidine metabolic process (GO:0046087) | 3.54739731 |
| 111 | cytidine catabolic process (GO:0006216) | 3.54739731 |
| 112 | positive regulation of cation channel activity (GO:2001259) | 3.52958298 |
| 113 | glycogen biosynthetic process (GO:0005978) | 3.52275690 |
| 114 | glucan biosynthetic process (GO:0009250) | 3.52275690 |
| 115 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.52264994 |
| 116 | regulation of ATP catabolic process (GO:1903289) | 3.49795521 |
| 117 | regulation of ATPase activity (GO:0043462) | 3.49795521 |
| 118 | cardiac muscle cell action potential (GO:0086001) | 3.49606173 |
| 119 | negative regulation of protein localization to cell surface (GO:2000009) | 3.49505229 |
| 120 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.47945345 |
| 121 | hexose biosynthetic process (GO:0019319) | 3.42368972 |
| 122 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.41664928 |
| 123 | myoblast fusion (GO:0007520) | 3.34926918 |
| 124 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.33742882 |
| 125 | muscle cell development (GO:0055001) | 3.33348934 |
| 126 | regulation of muscle system process (GO:0090257) | 3.30432218 |
| 127 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.29262274 |
| 128 | neuronal action potential propagation (GO:0019227) | 3.25531659 |
| 129 | myotube differentiation (GO:0014902) | 3.23957425 |
| 130 | regulation of muscle contraction (GO:0006937) | 3.22756487 |
| 131 | striated muscle tissue development (GO:0014706) | 3.21997328 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.60288915 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.72382049 |
| 3 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.34560227 |
| 4 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.08256009 |
| 5 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.94574567 |
| 6 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.82256295 |
| 7 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.82256295 |
| 8 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.43203799 |
| 9 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.21953045 |
| 10 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.83094598 |
| 11 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.73283707 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.71791646 |
| 13 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.36974081 |
| 14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.21419231 |
| 15 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.19387780 |
| 16 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.15835061 |
| 17 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.14126009 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.08516338 |
| 19 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.02280845 |
| 20 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.91932477 |
| 21 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.85840410 |
| 22 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.68018095 |
| 23 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.67064161 |
| 24 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.66664096 |
| 25 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.64658619 |
| 26 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.58312125 |
| 27 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.58258146 |
| 28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.57083045 |
| 29 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.54931305 |
| 30 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.50308414 |
| 31 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.49274324 |
| 32 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.46074194 |
| 33 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.43155877 |
| 34 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.38940348 |
| 35 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.38028124 |
| 36 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.29370287 |
| 37 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.29049837 |
| 38 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.28080361 |
| 39 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.27047266 |
| 40 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.26197347 |
| 41 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.25968137 |
| 42 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.25480703 |
| 43 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.18881193 |
| 44 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.17159214 |
| 45 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.16658298 |
| 46 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.16567114 |
| 47 | GATA1_22025678_ChIP-Seq_K562_Human | 1.16436843 |
| 48 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.16164288 |
| 49 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.15439761 |
| 50 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.14201080 |
| 51 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.12642925 |
| 52 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.11984043 |
| 53 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.10661876 |
| 54 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.08451147 |
| 55 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.06799133 |
| 56 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.06525090 |
| 57 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.06518424 |
| 58 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.05459899 |
| 59 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.04954773 |
| 60 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.04221453 |
| 61 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.03271004 |
| 62 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.02945472 |
| 63 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.02589360 |
| 64 | P68_20966046_ChIP-Seq_HELA_Human | 1.00234969 |
| 65 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.00120922 |
| 66 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.97801320 |
| 67 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.97206102 |
| 68 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.97156823 |
| 69 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.97083611 |
| 70 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.96978536 |
| 71 | ATF3_27146783_Chip-Seq_COLON_Human | 0.96606641 |
| 72 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.95581014 |
| 73 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95402540 |
| 74 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.94622856 |
| 75 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.93887399 |
| 76 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.93191466 |
| 77 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.93014834 |
| 78 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.92560367 |
| 79 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.92157770 |
| 80 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.92042770 |
| 81 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.91777261 |
| 82 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.91664270 |
| 83 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.91065274 |
| 84 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.90729574 |
| 85 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.90340708 |
| 86 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88677369 |
| 87 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.88105387 |
| 88 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.88026938 |
| 89 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86569101 |
| 90 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.86178072 |
| 91 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.85361204 |
| 92 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.85180645 |
| 93 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.84939194 |
| 94 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84916014 |
| 95 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.84540982 |
| 96 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.83458611 |
| 97 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.83445577 |
| 98 | SA1_27219007_Chip-Seq_Bcells_Human | 0.83183773 |
| 99 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.82452273 |
| 100 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.82193238 |
| 101 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.81411479 |
| 102 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.81374726 |
| 103 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.80071353 |
| 104 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.79861004 |
| 105 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.79800908 |
| 106 | CJUN_26792858_Chip-Seq_BT549_Human | 0.79664220 |
| 107 | GATA2_19941826_ChIP-Seq_K562_Human | 0.78966081 |
| 108 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.78381146 |
| 109 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.77905857 |
| 110 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.77722159 |
| 111 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.77603025 |
| 112 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.77295154 |
| 113 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.77088628 |
| 114 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.77069797 |
| 115 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.77059069 |
| 116 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.76097014 |
| 117 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.75779875 |
| 118 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.75342363 |
| 119 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.75131902 |
| 120 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.75094421 |
| 121 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.75029025 |
| 122 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.74954885 |
| 123 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.74850825 |
| 124 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.74795557 |
| 125 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.74265904 |
| 126 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.73821073 |
| 127 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.73758047 |
| 128 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.73549164 |
| 129 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.73031057 |
| 130 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.72731062 |
| 131 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.72208488 |
| 132 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.72009663 |
| 133 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.72009663 |
| 134 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.70942983 |
| 135 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.70919399 |
| 136 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.69441895 |
| 137 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.66808861 |
| 138 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.65808404 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 6.36621802 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 6.11234658 |
| 3 | MP0000751_myopathy | 5.62813701 |
| 4 | MP0000749_muscle_degeneration | 4.91355444 |
| 5 | MP0004084_abnormal_cardiac_muscle | 4.65238990 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.48105988 |
| 7 | MP0004145_abnormal_muscle_electrophysio | 4.46192695 |
| 8 | MP0004215_abnormal_myocardial_fiber | 3.91277089 |
| 9 | MP0005330_cardiomyopathy | 3.40192615 |
| 10 | MP0004087_abnormal_muscle_fiber | 3.35166675 |
| 11 | MP0002106_abnormal_muscle_physiology | 3.29574377 |
| 12 | MP0000750_abnormal_muscle_regeneration | 3.08572907 |
| 13 | MP0004130_abnormal_muscle_cell | 3.03012060 |
| 14 | MP0005620_abnormal_muscle_contractility | 3.02363465 |
| 15 | MP0000747_muscle_weakness | 2.93819511 |
| 16 | MP0002269_muscular_atrophy | 2.86468840 |
| 17 | MP0000759_abnormal_skeletal_muscle | 2.74588602 |
| 18 | MP0005369_muscle_phenotype | 2.69047986 |
| 19 | MP0002972_abnormal_cardiac_muscle | 2.65702386 |
| 20 | MP0003137_abnormal_impulse_conducting | 2.34931620 |
| 21 | MP0008775_abnormal_heart_ventricle | 2.26312368 |
| 22 | MP0004484_altered_response_of | 2.25421870 |
| 23 | MP0010630_abnormal_cardiac_muscle | 2.23738750 |
| 24 | MP0005385_cardiovascular_system_phenoty | 2.16360653 |
| 25 | MP0001544_abnormal_cardiovascular_syste | 2.16360653 |
| 26 | MP0004233_abnormal_muscle_weight | 2.11939622 |
| 27 | MP0006036_abnormal_mitochondrial_physio | 1.95657907 |
| 28 | MP0002332_abnormal_exercise_endurance | 1.82325245 |
| 29 | MP0006138_congestive_heart_failure | 1.82273921 |
| 30 | MP0003221_abnormal_cardiomyocyte_apopto | 1.75525138 |
| 31 | MP0003828_pulmonary_edema | 1.67480011 |
| 32 | MP0004085_abnormal_heartbeat | 1.62330036 |
| 33 | MP0005666_abnormal_adipose_tissue | 1.52828201 |
| 34 | MP0003950_abnormal_plasma_membrane | 1.41486316 |
| 35 | MP0004510_myositis | 1.35997019 |
| 36 | MP0004185_abnormal_adipocyte_glucose | 1.33175078 |
| 37 | MP0002108_abnormal_muscle_morphology | 1.29327858 |
| 38 | MP0002127_abnormal_cardiovascular_syste | 1.28845913 |
| 39 | MP0000733_abnormal_muscle_development | 1.22467279 |
| 40 | MP0006035_abnormal_mitochondrial_morpho | 1.11880819 |
| 41 | MP0000343_altered_response_to | 1.06823850 |
| 42 | MP0005375_adipose_tissue_phenotype | 1.04383596 |
| 43 | MP0002234_abnormal_pharynx_morphology | 1.00208664 |
| 44 | MP0005670_abnormal_white_adipose | 0.99591702 |
| 45 | MP0003567_abnormal_fetal_cardiomyocyte | 0.98749140 |
| 46 | MP0000266_abnormal_heart_morphology | 0.98581748 |
| 47 | MP0005266_abnormal_metabolism | 0.96471193 |
| 48 | MP0003806_abnormal_nucleotide_metabolis | 0.93123519 |
| 49 | MP0001661_extended_life_span | 0.89499435 |
| 50 | MP0002971_abnormal_brown_adipose | 0.87247630 |
| 51 | MP0005165_increased_susceptibility_to | 0.83308475 |
| 52 | MP0003705_abnormal_hypodermis_morpholog | 0.74319146 |
| 53 | MP0010368_abnormal_lymphatic_system | 0.72883199 |
| 54 | MP0004043_abnormal_pH_regulation | 0.72814297 |
| 55 | MP0003279_aneurysm | 0.68631167 |
| 56 | MP0000230_abnormal_systemic_arterial | 0.68474301 |
| 57 | MP0004147_increased_porphyrin_level | 0.68127272 |
| 58 | MP0000013_abnormal_adipose_tissue | 0.66304875 |
| 59 | MP0002128_abnormal_blood_circulation | 0.61801594 |
| 60 | MP0000003_abnormal_adipose_tissue | 0.58466423 |
| 61 | MP0000372_irregular_coat_pigmentation | 0.56669964 |
| 62 | MP0002078_abnormal_glucose_homeostasis | 0.56554224 |
| 63 | MP0008961_abnormal_basal_metabolism | 0.54477451 |
| 64 | MP0003879_abnormal_hair_cell | 0.50428257 |
| 65 | MP0001879_abnormal_lymphatic_vessel | 0.48836765 |
| 66 | MP0004134_abnormal_chest_morphology | 0.48176185 |
| 67 | MP0005319_abnormal_enzyme/_coenzyme | 0.48160618 |
| 68 | MP0005275_abnormal_skin_tensile | 0.46450546 |
| 69 | MP0005623_abnormal_meninges_morphology | 0.46400367 |
| 70 | MP0002909_abnormal_adrenal_gland | 0.45772613 |
| 71 | MP0003566_abnormal_cell_adhesion | 0.45067644 |
| 72 | MP0005187_abnormal_penis_morphology | 0.42061596 |
| 73 | MP0005334_abnormal_fat_pad | 0.41437120 |
| 74 | MP0010030_abnormal_orbit_morphology | 0.40873629 |
| 75 | MP0005451_abnormal_body_composition | 0.39959524 |
| 76 | MP0000767_abnormal_smooth_muscle | 0.38510808 |
| 77 | MP0003656_abnormal_erythrocyte_physiolo | 0.37568971 |
| 78 | MP0005083_abnormal_biliary_tract | 0.37065927 |
| 79 | MP0008438_abnormal_cutaneous_collagen | 0.36001071 |
| 80 | MP0005166_decreased_susceptibility_to | 0.35863831 |
| 81 | MP0005535_abnormal_body_temperature | 0.35086437 |
| 82 | MP0002925_abnormal_cardiovascular_devel | 0.32665597 |
| 83 | MP0004142_abnormal_muscle_tone | 0.32639593 |
| 84 | MP0003948_abnormal_gas_homeostasis | 0.32200003 |
| 85 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.31441196 |
| 86 | MP0002822_catalepsy | 0.30547897 |
| 87 | MP0009672_abnormal_birth_weight | 0.29370408 |
| 88 | MP0002638_abnormal_pupillary_reflex | 0.29280399 |
| 89 | MP0002114_abnormal_axial_skeleton | 0.29000209 |
| 90 | MP0001346_abnormal_lacrimal_gland | 0.27596808 |
| 91 | MP0003195_calcinosis | 0.26860604 |
| 92 | MP0002118_abnormal_lipid_homeostasis | 0.26721512 |
| 93 | MP0005452_abnormal_adipose_tissue | 0.26567325 |
| 94 | MP0003045_fibrosis | 0.25981204 |
| 95 | MP0001299_abnormal_eye_distance/ | 0.25596696 |
| 96 | MP0009115_abnormal_fat_cell | 0.25488752 |
| 97 | MP0005332_abnormal_amino_acid | 0.25155939 |
| 98 | MP0004272_abnormal_basement_membrane | 0.25011420 |
| 99 | MP0001614_abnormal_blood_vessel | 0.24737682 |
| 100 | MP0001784_abnormal_fluid_regulation | 0.24471394 |
| 101 | MP0008569_lethality_at_weaning | 0.24031790 |
| 102 | MP0009780_abnormal_chondrocyte_physiolo | 0.23862647 |
| 103 | MP0009250_abnormal_appendicular_skeleto | 0.23587384 |
| 104 | MP0002734_abnormal_mechanical_nocicepti | 0.23452643 |
| 105 | MP0001853_heart_inflammation | 0.22470984 |
| 106 | MP0004270_analgesia | 0.22151096 |
| 107 | MP0005376_homeostasis/metabolism_phenot | 0.20765389 |
| 108 | MP0001943_abnormal_respiration | 0.20142105 |
| 109 | MP0002066_abnormal_motor_capabilities/c | 0.20077622 |
| 110 | MP0009840_abnormal_foam_cell | 0.18181408 |
| 111 | MP0005167_abnormal_blood-brain_barrier | 0.17961593 |
| 112 | MP0001727_abnormal_embryo_implantation | 0.17601934 |
| 113 | MP0003984_embryonic_growth_retardation | 0.17332387 |
| 114 | MP0000762_abnormal_tongue_morphology | 0.16724762 |
| 115 | MP0002088_abnormal_embryonic_growth/wei | 0.16301557 |
| 116 | MP0002896_abnormal_bone_mineralization | 0.15945575 |
| 117 | MP0008874_decreased_physiological_sensi | 0.15055862 |
| 118 | MP0003959_abnormal_lean_body | 0.14903835 |
| 119 | MP0005423_abnormal_somatic_nervous | 0.14466581 |
| 120 | MP0006276_abnormal_autonomic_nervous | 0.11100536 |
| 121 | MP0002067_abnormal_sensory_capabilities | 0.10771377 |
| 122 | MP0005386_behavior/neurological_phenoty | 0.10622206 |
| 123 | MP0004924_abnormal_behavior | 0.10622206 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 7.92543774 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 7.61453174 |
| 3 | Muscle hypertrophy of the lower extremities (HP:0008968) | 7.10955798 |
| 4 | Calf muscle hypertrophy (HP:0008981) | 7.01036274 |
| 5 | Sudden death (HP:0001699) | 6.37416320 |
| 6 | Muscle fiber splitting (HP:0003555) | 5.85545704 |
| 7 | Myoglobinuria (HP:0002913) | 5.71665103 |
| 8 | Muscle fiber inclusion bodies (HP:0100299) | 5.71514587 |
| 9 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.55499129 |
| 10 | Ventricular tachycardia (HP:0004756) | 5.37213611 |
| 11 | Hyporeflexia of lower limbs (HP:0002600) | 5.21654822 |
| 12 | Abnormality of the calf musculature (HP:0001430) | 5.19498503 |
| 13 | Difficulty running (HP:0009046) | 4.90753918 |
| 14 | Nemaline bodies (HP:0003798) | 4.90573863 |
| 15 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.82946270 |
| 16 | Subaortic stenosis (HP:0001682) | 4.82946270 |
| 17 | EMG: myopathic abnormalities (HP:0003458) | 4.61503776 |
| 18 | Rhabdomyolysis (HP:0003201) | 4.59363573 |
| 19 | Type 1 muscle fiber predominance (HP:0003803) | 4.55050491 |
| 20 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.54240305 |
| 21 | Increased connective tissue (HP:0009025) | 4.51494725 |
| 22 | Atrial fibrillation (HP:0005110) | 4.27923849 |
| 23 | Myotonia (HP:0002486) | 4.22389921 |
| 24 | Lipoatrophy (HP:0100578) | 4.07712223 |
| 25 | Primary atrial arrhythmia (HP:0001692) | 3.99705564 |
| 26 | Distal arthrogryposis (HP:0005684) | 3.96387331 |
| 27 | Muscle stiffness (HP:0003552) | 3.89615886 |
| 28 | Asymmetric septal hypertrophy (HP:0001670) | 3.88765405 |
| 29 | Supraventricular tachycardia (HP:0004755) | 3.85997703 |
| 30 | Supraventricular arrhythmia (HP:0005115) | 3.78045085 |
| 31 | Myopathic facies (HP:0002058) | 3.66737771 |
| 32 | Right ventricular cardiomyopathy (HP:0011663) | 3.58911691 |
| 33 | Bundle branch block (HP:0011710) | 3.56935817 |
| 34 | Round ear (HP:0100830) | 3.55859055 |
| 35 | Dilated cardiomyopathy (HP:0001644) | 3.53439619 |
| 36 | Difficulty climbing stairs (HP:0003551) | 3.46788883 |
| 37 | Palpitations (HP:0001962) | 3.44152781 |
| 38 | Syncope (HP:0001279) | 3.38532200 |
| 39 | Prolonged QT interval (HP:0001657) | 3.26339283 |
| 40 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.22058200 |
| 41 | Increased variability in muscle fiber diameter (HP:0003557) | 3.16470941 |
| 42 | Ulnar deviation of the wrist (HP:0003049) | 3.13258958 |
| 43 | Ventricular arrhythmia (HP:0004308) | 3.06643056 |
| 44 | Heart block (HP:0012722) | 2.98613698 |
| 45 | Areflexia of lower limbs (HP:0002522) | 2.97490607 |
| 46 | Neck muscle weakness (HP:0000467) | 2.93321541 |
| 47 | Abnormal atrioventricular conduction (HP:0005150) | 2.81654653 |
| 48 | Distal lower limb muscle weakness (HP:0009053) | 2.78133268 |
| 49 | Rimmed vacuoles (HP:0003805) | 2.75293804 |
| 50 | Ventricular fibrillation (HP:0001663) | 2.70155644 |
| 51 | Atrioventricular block (HP:0001678) | 2.70149121 |
| 52 | Bulbar palsy (HP:0001283) | 2.59547485 |
| 53 | Calcaneovalgus deformity (HP:0001848) | 2.56068232 |
| 54 | Abnormality of the calcaneus (HP:0008364) | 2.47769473 |
| 55 | Absent phalangeal crease (HP:0006109) | 2.44850736 |
| 56 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.44370515 |
| 57 | Limb-girdle muscle atrophy (HP:0003797) | 2.43987671 |
| 58 | Weak cry (HP:0001612) | 2.43558917 |
| 59 | Fetal akinesia sequence (HP:0001989) | 2.43098761 |
| 60 | Hepatic necrosis (HP:0002605) | 2.42058700 |
| 61 | Slender build (HP:0001533) | 2.40402113 |
| 62 | Acute necrotizing encephalopathy (HP:0006965) | 2.38440472 |
| 63 | Abnormal EKG (HP:0003115) | 2.36766013 |
| 64 | Hypoplastic ischia (HP:0003175) | 2.35745528 |
| 65 | Left ventricular hypertrophy (HP:0001712) | 2.34900674 |
| 66 | Deformed tarsal bones (HP:0008119) | 2.27814532 |
| 67 | Ketoacidosis (HP:0001993) | 2.27470423 |
| 68 | EMG: neuropathic changes (HP:0003445) | 2.27426778 |
| 69 | Muscular dystrophy (HP:0003560) | 2.27241570 |
| 70 | Frequent falls (HP:0002359) | 2.23609495 |
| 71 | Spinal rigidity (HP:0003306) | 2.21524973 |
| 72 | Hip contracture (HP:0003273) | 2.19507611 |
| 73 | Generalized muscle weakness (HP:0003324) | 2.17053485 |
| 74 | Gowers sign (HP:0003391) | 2.14944437 |
| 75 | Distal lower limb amyotrophy (HP:0008944) | 2.14214763 |
| 76 | Hepatocellular necrosis (HP:0001404) | 2.12783476 |
| 77 | Increased muscle lipid content (HP:0009058) | 2.10514124 |
| 78 | Facial diplegia (HP:0001349) | 2.10081984 |
| 79 | Exercise intolerance (HP:0003546) | 2.09843872 |
| 80 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.09073320 |
| 81 | Acute encephalopathy (HP:0006846) | 2.07083389 |
| 82 | Malignant hyperthermia (HP:0002047) | 2.06833565 |
| 83 | Abnormality of the ischium (HP:0003174) | 2.05366008 |
| 84 | Proximal amyotrophy (HP:0007126) | 2.03420584 |
| 85 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.99661321 |
| 86 | Waddling gait (HP:0002515) | 1.99145264 |
| 87 | Testicular atrophy (HP:0000029) | 1.99074247 |
| 88 | Palmoplantar keratoderma (HP:0000982) | 1.98996031 |
| 89 | Foot dorsiflexor weakness (HP:0009027) | 1.98684242 |
| 90 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.98574079 |
| 91 | Lower limb amyotrophy (HP:0007210) | 1.97740522 |
| 92 | Limb-girdle muscle weakness (HP:0003325) | 1.97702646 |
| 93 | Progressive macrocephaly (HP:0004481) | 1.97447032 |
| 94 | Abnormal finger flexion creases (HP:0006143) | 1.97372210 |
| 95 | Hypoglycemic coma (HP:0001325) | 1.96719108 |
| 96 | Mitochondrial inheritance (HP:0001427) | 1.94495737 |
| 97 | Abnormality of alanine metabolism (HP:0010916) | 1.92126649 |
| 98 | Hyperalaninemia (HP:0003348) | 1.92126649 |
| 99 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.92126649 |
| 100 | Scapular winging (HP:0003691) | 1.91981122 |
| 101 | Conjunctival hamartoma (HP:0100780) | 1.90670450 |
| 102 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.90261667 |
| 103 | Progressive muscle weakness (HP:0003323) | 1.88134219 |
| 104 | Ragged-red muscle fibers (HP:0003200) | 1.87689527 |
| 105 | Hyperkalemia (HP:0002153) | 1.87513886 |
| 106 | Dicarboxylic aciduria (HP:0003215) | 1.87056311 |
| 107 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.87056311 |
| 108 | Increased intramyocellular lipid droplets (HP:0012240) | 1.86787184 |
| 109 | Cerebral edema (HP:0002181) | 1.86750039 |
| 110 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.86587767 |
| 111 | Increased CSF lactate (HP:0002490) | 1.85255549 |
| 112 | Abnormality of the neuromuscular junction (HP:0003398) | 1.84537644 |
| 113 | Fatigable weakness (HP:0003473) | 1.84537644 |
| 114 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.78054588 |
| 115 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.78054588 |
| 116 | Abnormality of the foot musculature (HP:0001436) | 1.76449450 |
| 117 | Shoulder girdle muscle weakness (HP:0003547) | 1.72595330 |
| 118 | Metatarsus adductus (HP:0001840) | 1.72444410 |
| 119 | Pelvic girdle muscle weakness (HP:0003749) | 1.71813539 |
| 120 | Nonprogressive disorder (HP:0003680) | 1.61267974 |
| 121 | Paralysis (HP:0003470) | 1.58969392 |
| 122 | Popliteal pterygium (HP:0009756) | 1.58931952 |
| 123 | Long clavicles (HP:0000890) | 1.57654004 |
| 124 | Ulnar deviation of finger (HP:0009465) | 1.53060540 |
| 125 | Type 2 muscle fiber atrophy (HP:0003554) | 1.52814380 |
| 126 | Limited hip movement (HP:0008800) | 1.45358323 |
| 127 | Muscle fiber atrophy (HP:0100295) | 1.41344157 |
| 128 | Steppage gait (HP:0003376) | 1.39352690 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 6.82627112 |
| 2 | OBSCN | 5.60303065 |
| 3 | PHKG2 | 5.20940858 |
| 4 | PHKG1 | 5.20940858 |
| 5 | PDK3 | 3.27708497 |
| 6 | PDK4 | 3.27708497 |
| 7 | DMPK | 2.66250115 |
| 8 | LMTK2 | 2.58588339 |
| 9 | NEK1 | 2.54452527 |
| 10 | TRIB3 | 2.53702218 |
| 11 | BCKDK | 2.35333199 |
| 12 | MYLK | 2.35126758 |
| 13 | PKN2 | 2.31683560 |
| 14 | PIK3CA | 2.30077093 |
| 15 | PINK1 | 2.28703530 |
| 16 | PDK2 | 2.05422965 |
| 17 | MUSK | 1.98502872 |
| 18 | NME1 | 1.87405504 |
| 19 | MAP2K3 | 1.80270143 |
| 20 | STK24 | 1.78839566 |
| 21 | TIE1 | 1.62661186 |
| 22 | MAP3K7 | 1.59698081 |
| 23 | PIK3CG | 1.43720829 |
| 24 | MAPK12 | 1.35189401 |
| 25 | ILK | 0.99373920 |
| 26 | GRK7 | 0.98784221 |
| 27 | PRKD1 | 0.94233001 |
| 28 | CCNB1 | 0.93628997 |
| 29 | PRKAA1 | 0.93505755 |
| 30 | PRKAA2 | 0.92762795 |
| 31 | MARK1 | 0.91400787 |
| 32 | PAK3 | 0.91211980 |
| 33 | CAMK2D | 0.89978601 |
| 34 | LIMK1 | 0.85706274 |
| 35 | MAPKAPK3 | 0.85455962 |
| 36 | TRPM7 | 0.85230495 |
| 37 | MOS | 0.79091323 |
| 38 | MAP2K4 | 0.79064029 |
| 39 | ZAK | 0.73321402 |
| 40 | RIPK1 | 0.71555085 |
| 41 | MAP3K5 | 0.70896754 |
| 42 | DYRK1B | 0.70424732 |
| 43 | MAP3K3 | 0.70348439 |
| 44 | ROCK1 | 0.68902105 |
| 45 | NEK9 | 0.68036627 |
| 46 | MAP2K6 | 0.65995182 |
| 47 | INSRR | 0.62609820 |
| 48 | PKN1 | 0.59943740 |
| 49 | EPHB1 | 0.58026969 |
| 50 | MAP3K13 | 0.56321114 |
| 51 | FLT3 | 0.54901375 |
| 52 | CAMK4 | 0.51382269 |
| 53 | STK4 | 0.51118824 |
| 54 | WNK4 | 0.49596840 |
| 55 | CDC42BPA | 0.49198455 |
| 56 | KSR2 | 0.47834575 |
| 57 | PDGFRA | 0.46884126 |
| 58 | STK38L | 0.46604516 |
| 59 | MAP2K1 | 0.45992321 |
| 60 | CAMK2G | 0.45087256 |
| 61 | PRKACB | 0.44389129 |
| 62 | CAMK2B | 0.41883831 |
| 63 | TGFBR2 | 0.41762098 |
| 64 | AKT2 | 0.40869445 |
| 65 | ROCK2 | 0.39252221 |
| 66 | CAMK2A | 0.38968156 |
| 67 | PTK6 | 0.38101595 |
| 68 | STK38 | 0.37592054 |
| 69 | SIK1 | 0.36787449 |
| 70 | WNK1 | 0.36774730 |
| 71 | TBK1 | 0.36404732 |
| 72 | PDPK1 | 0.35519556 |
| 73 | DAPK3 | 0.34567287 |
| 74 | PRKACA | 0.33695767 |
| 75 | KDR | 0.33512834 |
| 76 | CAMK1 | 0.32787024 |
| 77 | PTK2B | 0.32000483 |
| 78 | RPS6KL1 | 0.31686504 |
| 79 | RPS6KC1 | 0.31686504 |
| 80 | MAPK11 | 0.31657287 |
| 81 | ICK | 0.31137043 |
| 82 | PDK1 | 0.29995387 |
| 83 | SGK2 | 0.29323503 |
| 84 | PRKACG | 0.28567958 |
| 85 | TAOK1 | 0.28106460 |
| 86 | MAP3K11 | 0.27444812 |
| 87 | ARAF | 0.26198862 |
| 88 | MAPK13 | 0.25773451 |
| 89 | RPS6KA6 | 0.25138044 |
| 90 | RPS6KB1 | 0.23831549 |
| 91 | SGK1 | 0.22940296 |
| 92 | MAPK10 | 0.22856540 |
| 93 | RPS6KA1 | 0.21887037 |
| 94 | MAP3K10 | 0.21304164 |
| 95 | TAOK2 | 0.21251019 |
| 96 | PRKG1 | 0.20510588 |
| 97 | RPS6KA3 | 0.19486285 |
| 98 | NME2 | 0.18452798 |
| 99 | MAPK7 | 0.18351709 |
| 100 | MAP3K1 | 0.17779108 |
| 101 | RPS6KB2 | 0.17103351 |
| 102 | PRKCH | 0.16721990 |
| 103 | MARK2 | 0.16533223 |
| 104 | DAPK2 | 0.15976176 |
| 105 | PRKCE | 0.15743980 |
| 106 | RAF1 | 0.15639244 |
| 107 | STK39 | 0.15339564 |
| 108 | RET | 0.14052701 |
| 109 | PAK6 | 0.13886112 |
| 110 | MAP3K6 | 0.13619432 |
| 111 | MTOR | 0.13106901 |
| 112 | LATS1 | 0.12968418 |
| 113 | SGK3 | 0.12774661 |
| 114 | LATS2 | 0.12434364 |
| 115 | PRPF4B | 0.12405390 |
| 116 | LRRK2 | 0.12342370 |
| 117 | SGK223 | 0.11565343 |
| 118 | SGK494 | 0.11565343 |
| 119 | EEF2K | 0.11352600 |
| 120 | ZAP70 | 0.09668628 |
| 121 | JAK1 | 0.09027543 |
| 122 | MAPK4 | 0.08777674 |
| 123 | CDK19 | 0.08761001 |
| 124 | FER | 0.07737271 |
| 125 | ERBB3 | 0.07431894 |
| 126 | RPS6KA2 | 0.06870470 |
| 127 | PRKG2 | 0.06754994 |
| 128 | BRAF | 0.06473931 |
| 129 | MARK3 | 0.04966332 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.75240376 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.23151501 |
| 3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.14265634 |
| 4 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.79889663 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.65853756 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.21381431 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.12001442 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 2.93068552 |
| 9 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.80736367 |
| 10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.80071003 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.71260824 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.50114197 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 2.26229604 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.21762287 |
| 15 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.11316751 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.02718263 |
| 17 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.77094730 |
| 18 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.74350558 |
| 19 | Huntingtons disease_Homo sapiens_hsa05016 | 1.71006162 |
| 20 | Viral myocarditis_Homo sapiens_hsa05416 | 1.65462409 |
| 21 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.56884320 |
| 22 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.48025982 |
| 23 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.42704979 |
| 24 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.39388481 |
| 25 | Insulin resistance_Homo sapiens_hsa04931 | 1.36433722 |
| 26 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.27220236 |
| 27 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.23630462 |
| 28 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.23514062 |
| 29 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.23274393 |
| 30 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.09968097 |
| 31 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.07286366 |
| 32 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.04224876 |
| 33 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.03806588 |
| 34 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.97563558 |
| 35 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.95288792 |
| 36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.93359746 |
| 37 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.90865659 |
| 38 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.90181222 |
| 39 | Galactose metabolism_Homo sapiens_hsa00052 | 0.89598649 |
| 40 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.87159492 |
| 41 | Circadian rhythm_Homo sapiens_hsa04710 | 0.85654320 |
| 42 | Long-term potentiation_Homo sapiens_hsa04720 | 0.83101427 |
| 43 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.81330965 |
| 44 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.80509500 |
| 45 | Focal adhesion_Homo sapiens_hsa04510 | 0.76276186 |
| 46 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.74192826 |
| 47 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.72650852 |
| 48 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.70416092 |
| 49 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.67915274 |
| 50 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.66974150 |
| 51 | Tight junction_Homo sapiens_hsa04530 | 0.66939910 |
| 52 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.65190517 |
| 53 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.60936289 |
| 54 | Lysine degradation_Homo sapiens_hsa00310 | 0.60620327 |
| 55 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.57685179 |
| 56 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.55937314 |
| 57 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52657494 |
| 58 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.51908431 |
| 59 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.51257380 |
| 60 | Renin secretion_Homo sapiens_hsa04924 | 0.49834254 |
| 61 | Peroxisome_Homo sapiens_hsa04146 | 0.44429852 |
| 62 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.41452566 |
| 63 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.39844480 |
| 64 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.39598093 |
| 65 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.37801033 |
| 66 | Insulin secretion_Homo sapiens_hsa04911 | 0.37078491 |
| 67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.36920410 |
| 68 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.35407546 |
| 69 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.33855655 |
| 70 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.33360341 |
| 71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32045600 |
| 72 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.30406458 |
| 73 | Amoebiasis_Homo sapiens_hsa05146 | 0.30247763 |
| 74 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.30144797 |
| 75 | Adherens junction_Homo sapiens_hsa04520 | 0.30141104 |
| 76 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.28993465 |
| 77 | Long-term depression_Homo sapiens_hsa04730 | 0.28340356 |
| 78 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.28142084 |
| 79 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.26332207 |
| 80 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.25453958 |
| 81 | Platelet activation_Homo sapiens_hsa04611 | 0.25364008 |
| 82 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.25305613 |
| 83 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.25001340 |
| 84 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.23786595 |
| 85 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.23472284 |
| 86 | Histidine metabolism_Homo sapiens_hsa00340 | 0.23079247 |
| 87 | Melanogenesis_Homo sapiens_hsa04916 | 0.22892673 |
| 88 | Metabolic pathways_Homo sapiens_hsa01100 | 0.21934453 |
| 89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.21144874 |
| 90 | Glioma_Homo sapiens_hsa05214 | 0.19936289 |
| 91 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.19648196 |
| 92 | Circadian entrainment_Homo sapiens_hsa04713 | 0.18597074 |
| 93 | Purine metabolism_Homo sapiens_hsa00230 | 0.17261064 |
| 94 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.15947328 |
| 95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.15868838 |
| 96 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.15815431 |
| 97 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.15316680 |
| 98 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.13146536 |
| 99 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.11120112 |
| 100 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.11024639 |
| 101 | Olfactory transduction_Homo sapiens_hsa04740 | 0.10923299 |
| 102 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.09746528 |
| 103 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.09341486 |
| 104 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.07165578 |
| 105 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.06960841 |
| 106 | Gap junction_Homo sapiens_hsa04540 | 0.06746455 |
| 107 | Sulfur relay system_Homo sapiens_hsa04122 | 0.06500928 |
| 108 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.06273527 |
| 109 | Bile secretion_Homo sapiens_hsa04976 | 0.03622168 |
| 110 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.02145657 |
| 111 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.02073276 |
| 112 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.01356480 |
| 113 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.00305775 |
| 114 | Salivary secretion_Homo sapiens_hsa04970 | -0.0573916 |
| 115 | ABC transporters_Homo sapiens_hsa02010 | -0.0310933 |
| 116 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | -0.0234811 |
| 117 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | -0.0126853 |

